With annual revenue of $44.4bn and an R&D expenditure of $6.3bn, this French multinational pharmaceutical company was the result of a merger between Sanofi and Aventis.
It deals with seven major therapeutic areas including oncology and thrombosis primarily for the prescription market .It also develops OTC medicines.
Sanofi has presence in Pharmaceuticals, Human Vaccines and animal health. Its main business is pharmaceuticals. It has 110000 employees across world. It has 107 manufacturing sites and 20 R&D centres. The history of the current company can be traced back to 1718. The current name Sanofi came into effect from 6th May 2011.
In 2004, Sanofi- Synthélabo and Aventis to form the current day Sanofi.